/Companies

Specie Bio

1 known investors

Find your way into Specie Bio

Sign up to see every warm intro you have to Specie Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Specie Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Specie Bio operates BioExchange, an AI-driven platform for finding, matching, and accessing biospecimens and multimodal clinical data from a global network of biobanks, hospitals, clinics, and non-profit institutions. It serves researchers across the R&D lifecycle for uses such as biomarker discovery, diagnostic test development, and training foundation models, with deep oncology and broad disease coverage.

Investors · 1

Frequently asked questions

What does Specie Bio do?
Specie Bio operates BioExchange, an AI-driven platform for finding, matching, and accessing biospecimens and multimodal clinical data from a global network of biobanks, hospitals, clinics, and non-profit institutions. It serves researchers across the R&D lifecycle for uses such as biomarker discovery, diagnostic test development, and training foundation models, with deep oncology and broad disease coverage.
Who are Specie Bio's investors?
Specie Bio's investors include Atria Ventures.